4-56523856-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001363794.2(ARL9):c.778C>G(p.Leu260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363794.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL9 | NM_001363794.2 | c.778C>G | p.Leu260Val | missense_variant | Exon 4 of 4 | ENST00000640821.3 | NP_001350723.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL9 | ENST00000640821.3 | c.778C>G | p.Leu260Val | missense_variant | Exon 4 of 4 | 5 | NM_001363794.2 | ENSP00000492671.3 | ||
ARL9 | ENST00000360096.3 | c.352C>G | p.Leu118Val | missense_variant | Exon 4 of 4 | 1 | ENSP00000353210.2 | |||
ARL9 | ENST00000645327.1 | n.*273C>G | non_coding_transcript_exon_variant | Exon 3 of 3 | ENSP00000496178.1 | |||||
ARL9 | ENST00000645327.1 | n.*273C>G | 3_prime_UTR_variant | Exon 3 of 3 | ENSP00000496178.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461356Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726970
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.352C>G (p.L118V) alteration is located in exon 4 (coding exon 3) of the ARL9 gene. This alteration results from a C to G substitution at nucleotide position 352, causing the leucine (L) at amino acid position 118 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at